cabozantinib

Focus on legal hammer

Pharma

Exelixis stock rises as Cabometyx withstands patent challenge

Exelixis' stock price rose on Tuesday after a favorable ruling from a Delaware federal judge effectively blocked Cabometyx generic entry out to 2030.

Angus Liu Oct 16, 2024 10:37am

Product image of Exelixis 60mg Cabometyx

Exelixis reveals Cabometyx data that led to early trial end

Oct 22, 2023 3:30am